bf/NYSE:ABBV_icon.jpeg

COM:ABBVIE

AbbVie Inc.

  • Stock

USD

Last Close

171.73

22/11 21:00

Market Cap

296.91B

Beta: -

Volume Today

11.33M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.12B
-
1.14B
1.47%
1.42B
25.02%
1.58B
11.26%
1.52B
3.60%
1.60B
5.28%
1.71B
6.48%
2.56B
49.88%
3.22B
25.67%
3.35B
4.18%
3.84B
14.48%
average payables
744.50M
-
907M
21.83%
1.24B
36.60%
1.50B
21.23%
1.44B
4.09%
1.51B
4.82%
1.50B
0.73%
1.86B
24.35%
2.58B
38.36%
2.91B
12.76%
3.31B
13.86%
average receivables
4.55B
-
4.55B
0.08%
4.51B
0.80%
4.74B
5.18%
4.92B
3.77%
5.24B
6.36%
5.41B
3.25%
7.13B
31.80%
9.40B
31.92%
10.62B
12.94%
11.20B
5.55%
book value per share
2.83
-
1.09
61.37%
2.43
122.28%
2.86
17.73%
3.19
11.73%
-5.48
271.62%
-5.52
0.68%
7.84
242.16%
8.71
10.98%
9.74
11.92%
5.84
40.02%
capex per share
-0.31
-
-0.38
24.17%
-0.33
14.68%
-0.30
9.80%
-0.33
12.24%
-0.41
24.91%
-0.37
9.97%
-0.48
28.43%
-0.44
7.12%
-0.39
11.74%
-0.44
11.67%
capex to depreciation
-0.55
-
-0.78
42.25%
-0.64
18.27%
-0.40
36.69%
-0.35
12.52%
-0.36
2.57%
-0.27
24.29%
-0.12
54.94%
-0.09
25.11%
-0.08
11.13%
-0.09
8.83%
capex to operating cash flow
-0.08
-
-0.17
120.10%
-0.07
59.06%
-0.07
3.65%
-0.05
21.93%
-0.05
10.54%
-0.04
12.81%
-0.05
9.52%
-0.03
23.85%
-0.03
19.36%
-0.03
22.10%
capex to revenue
-0.03
-
-0.03
17.34%
-0.02
24.10%
-0.02
19.72%
-0.02
0.35%
-0.02
3.90%
-0.02
14.81%
-0.02
4.99%
-0.01
19.62%
-0.01
14.51%
-0.01
19.49%
cash per share
6.23
-
5.25
15.69%
5.17
1.46%
3.96
23.46%
6.13
54.89%
5.23
14.71%
26.96
415.34%
5.09
81.13%
5.55
9.19%
5.21
6.17%
7.23
38.71%
days of inventory on hand
91.63
-
92.69
1.16%
139.43
50.42%
90.36
35.19%
83.21
7.91%
75.90
8.78%
88.96
17.20%
78.52
11.73%
65.44
16.65%
75.02
14.63%
170.40
127.15%
days payables outstanding
74.34
-
72.65
2.27%
129.53
78.29%
88.04
32.03%
76.42
13.20%
73.11
4.33%
71.24
2.56%
53.99
24.22%
60.30
11.68%
61.50
1.99%
153.32
149.31%
days sales outstanding
93.30
-
78.47
15.90%
75.53
3.75%
67.74
10.31%
65.82
2.83%
60.00
8.84%
59.56
0.74%
70.30
18.04%
64.80
7.82%
70.76
9.19%
74.96
5.94%
debt to assets
0.50
-
0.54
8.07%
0.60
9.56%
0.56
6.64%
0.53
5.29%
0.68
28.65%
0.75
10.25%
0.57
23.67%
0.52
8.44%
0.46
12.90%
0.44
3.29%
debt to equity
3.28
-
8.62
162.91%
8.03
6.83%
7.95
1.01%
7.33
7.75%
-4.77
165.10%
-8.17
71.09%
6.58
180.60%
4.98
24.38%
3.67
26.32%
5.73
56.32%
dividend yield
0.03
-
0.03
16.27%
0.03
34.22%
0.04
6.95%
0.03
27.29%
0.04
47.61%
0.05
23.60%
0.04
11.02%
0.04
10.55%
0.04
9.19%
0.04
9.31%
earnings yield
0.05
-
0.02
65.45%
0.05
214.40%
0.06
9.68%
0.03
41.31%
0.04
16.38%
0.06
50.16%
0.03
57.01%
0.05
86.36%
0.04
14.13%
0.02
57.20%
enterprise value
89.04B
-
111.04B
24.70%
119.54B
7.65%
133.31B
11.52%
182.41B
36.83%
175.09B
4.02%
157.93B
9.80%
256.23B
62.24%
306.60B
19.66%
340.28B
10.99%
321.33B
5.57%
enterprise value over ebitda
13.57
-
26.46
94.94%
14.28
46.04%
12.61
11.68%
16.44
30.42%
21.49
30.67%
11.45
46.72%
36.88
222.16%
11.59
68.57%
12.80
10.41%
17.76
38.72%
ev to operating cash flow
14.21
-
31.29
120.21%
15.86
49.30%
18.93
19.35%
18.31
3.27%
13.04
28.80%
11.85
9.10%
14.57
22.91%
13.46
7.60%
13.64
1.35%
14.07
3.13%
ev to sales
4.74
-
5.56
17.39%
5.23
6.00%
5.20
0.57%
6.46
24.33%
5.35
17.31%
4.75
11.19%
5.59
17.83%
5.46
2.47%
5.86
7.44%
5.92
0.93%
free cash flow per share
3.63
-
1.84
49.34%
4.31
134.04%
4.05
6.12%
5.91
46.06%
8.30
40.45%
8.62
3.91%
10.07
16.79%
12.42
23.35%
13.69
10.21%
12.44
9.12%
free cash flow yield
0.07
-
0.03
59.12%
0.07
158.53%
0.06
11.19%
0.06
5.42%
0.09
47.33%
0.10
8.20%
0.09
3.49%
0.09
2.39%
0.08
7.67%
0.08
5.22%
graham net net
-6.69
-
-8.56
27.89%
-22.33
160.95%
-31.29
40.10%
-32.13
2.69%
-35.62
10.87%
-35.37
0.71%
-72.42
104.73%
-63.40
12.45%
-57.63
9.10%
-57.01
1.07%
graham number
12.85
-
5.23
59.33%
13.15
151.52%
15.36
16.83%
15.46
0.63%
21.33
37.99%
25.71
20.49%
22.11
14.00%
35.74
61.66%
38.28
7.10%
18.99
50.39%
income quality
1.52
-
2.00
31.77%
1.46
26.78%
1.18
19.25%
1.88
58.62%
2.36
25.85%
1.69
28.40%
3.81
125.11%
1.97
48.17%
2.11
6.77%
4.68
122.11%
intangibles to total assets
0.28
-
0.27
4.29%
0.62
131.48%
0.67
8.18%
0.61
8.66%
0.62
1.52%
0.38
38.17%
0.77
100.44%
0.74
4.04%
0.72
2.95%
0.65
9.06%
interest coverage
20.37
-
8.72
57.18%
10.99
25.94%
9.72
11.49%
9.55
1.75%
5.58
41.60%
8.60
54.20%
0.21
97.57%
7.52
3,501.28%
8.12
8.06%
10.44
28.51%
interest debt per share
9.44
-
9.66
2.29%
19.91
106.20%
23.31
17.06%
24.04
3.15%
26.90
11.89%
46.07
71.28%
52.99
15.01%
44.67
15.70%
36.99
17.21%
34.44
6.89%
inventory turnover
3.98
-
3.94
1.15%
2.62
33.52%
4.04
54.31%
4.39
8.59%
4.81
9.63%
4.10
14.67%
4.65
13.29%
5.58
19.98%
4.87
12.76%
2.14
55.98%
invested capital
3.28
-
8.62
162.91%
8.03
6.83%
7.95
1.01%
7.33
7.75%
-4.77
165.10%
-8.17
71.09%
6.58
180.60%
4.98
24.38%
3.67
26.32%
5.73
56.32%
market cap
83.92B
-
104.38B
24.38%
96.27B
7.77%
101.57B
5.51%
154.35B
51.96%
142.06B
7.96%
131.13B
7.70%
178.62B
36.22%
239.66B
34.17%
286.21B
19.42%
274.76B
4.00%
net current asset value
-6.86B
-
-9.72B
41.69%
-32.79B
237.46%
-45.28B
38.07%
-44.47B
1.79%
-50.85B
14.36%
-47.77B
6.07%
-113.30B
137.18%
-103.17B
8.94%
-93.06B
9.80%
-91.31B
1.87%
net debt to ebitda
0.78
-
1.59
103.12%
2.78
75.07%
3.00
8.01%
2.53
15.73%
4.05
60.19%
1.94
52.06%
11.17
474.94%
2.53
77.34%
2.03
19.65%
2.57
26.53%
net income per share
2.60
-
1.11
57.19%
3.17
184.61%
3.67
15.94%
3.33
9.37%
3.69
10.94%
5.32
44.21%
2.77
47.97%
6.52
135.49%
6.68
2.49%
2.74
58.96%
operating cash flow per share
3.94
-
2.23
43.58%
4.64
108.39%
4.34
6.38%
6.24
43.76%
8.71
39.62%
9.00
3.25%
10.55
17.27%
12.87
21.97%
14.08
9.45%
12.88
8.54%
payables turnover
4.91
-
5.02
2.32%
2.82
43.91%
4.15
47.13%
4.78
15.21%
4.99
4.52%
5.12
2.62%
6.76
31.96%
6.05
10.46%
5.94
1.95%
2.38
59.89%
receivables turnover
3.91
-
4.65
18.90%
4.83
3.89%
5.39
11.50%
5.55
2.92%
6.08
9.70%
6.13
0.74%
5.19
15.28%
5.63
8.49%
5.16
8.42%
4.87
5.61%
research and ddevelopement to revenue
0.15
-
0.17
8.71%
0.19
13.48%
0.17
9.15%
0.18
3.68%
0.32
78.61%
0.19
38.93%
0.14
25.67%
0.13
11.94%
0.11
11.04%
0.13
15.45%
return on tangible assets
0.20
-
0.09
55.20%
0.25
189.95%
0.27
7.16%
0.19
29.20%
0.25
30.90%
0.14
43.27%
0.13
7.05%
0.30
126.26%
0.30
0.10%
0.10
65.58%
revenue per share
11.83
-
12.51
5.83%
14.07
12.41%
15.81
12.36%
17.68
11.85%
21.25
20.22%
22.46
5.68%
27.48
22.33%
31.75
15.55%
32.78
3.25%
30.64
6.54%
roe
0.92
-
1.02
10.82%
1.30
28.04%
1.28
1.52%
1.04
18.88%
-0.67
164.64%
-0.96
43.24%
0.35
136.60%
0.75
112.20%
0.69
8.42%
0.47
31.57%
roic
0.23
-
0.15
33.19%
0.16
7.44%
0.17
4.28%
0.16
9.15%
0.22
41.25%
0.21
5.38%
0.01
96.85%
0.17
2,549.61%
0.20
14.27%
0.19
1.49%
sales general and administrative to revenue
0.28
-
0.39
35.86%
0.28
27.80%
0.23
18.27%
0.22
2.62%
0.23
1.58%
shareholders equity per share
2.83
-
1.09
61.37%
2.43
122.28%
2.86
17.73%
3.19
11.73%
-5.48
271.62%
-5.52
0.68%
7.84
242.16%
8.71
10.98%
9.74
11.92%
5.84
40.02%
stock based compensation to revenue
0.01
-
0.01
7.02%
0.01
2.17%
0.01
11.61%
0.01
6.05%
0.01
0.63%
0.01
0.56%
0.02
27.18%
0.01
25.10%
0.01
6.14%
0.01
18.98%
tangible asset value
-3.67B
-
-5.63B
53.28%
-28.93B
413.62%
-39.68B
37.14%
-38.25B
3.60%
-45.34B
18.55%
-42.42B
6.43%
-102.90B
142.55%
-92.89B
9.73%
-82.31B
11.40%
-77.51B
5.83%
tangible book value per share
-2.31
-
-3.53
52.70%
-17.80
404.13%
-24.46
37.39%
-23.96
2.03%
-29.42
22.78%
-28.65
2.64%
-61.73
115.49%
-52.48
14.98%
-46.48
11.45%
-43.71
5.94%
working capital
10.97B
-
4.69B
57.26%
5.42B
15.61%
6.41B
18.19%
4.58B
28.47%
-294M
106.42%
33.93B
11,642.18%
-4.49B
113.23%
-7.27B
61.90%
-1.07B
85.21%
-4.84B
350.14%

All numbers in USD (except ratios and percentages)